Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sigall Budnik"'
Autor:
Diego, Reyes, Javier, Ortiz, Eduardo, Fuentes-López, Sigall, Budnik, Vicente, Gándara, Andrea, Gallardo, María Francisca, Seydewitz, Roberto, Candia, José Ignacio, Vargas, María Paz, Rollan, Javiera, Godoy, Antonio, Rollan, Rodrigo, Mansilla, Alex, Arenas, Javier, Chahuán, Alberto, Espino, Margarita, Pizarro, Arnoldo, Riquelme
Publikováno v:
Gastroenterología y Hepatología (English Edition). 45:515-523
Helicobacter pylori infection affects approximately 70% of the Chilean population. It is a public health problem whose eradication treatment is part of the explicit health guarantees in Chile.Characterize the most widely used H. pylori first-line era
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5929ec3250c9ed95e2a23fc4157aa8c8
https://doi.org/10.1016/j.gastre.2022.07.004
https://doi.org/10.1016/j.gastre.2022.07.004
Autor:
Diego Reyes, Javier Ortiz, Eduardo Fuentes-López, Sigall Budnik, Vicente Gándara, Andrea Gallardo, María Francisca Seydewitz, Roberto Candia, José Ignacio Vargas, María Paz Rollan, Javiera Godoy, Antonio Rollan, Rodrigo Mansilla, Alex Arenas, Javier Chahuán, Alberto Espino, Margarita Pizarro, Arnoldo Riquelme
Publikováno v:
Gastroenterología y Hepatología. 45:515-523
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44d62566f98bba96bc4334a14b24f431
https://doi.org/10.1016/j.gastrohep.2021.11.010
https://doi.org/10.1016/j.gastrohep.2021.11.010
Autor:
M Elvira Balcells, Nicole Le Corre, Josefina Durán, María Elena Ceballos, Cecilia Vizcaya, Sebastián Mondaca, Martín Dib, Ricardo Rabagliati, Mauricio Sarmiento, Paula I Burgos, Manuel Espinoza, Marcela Ferrés, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, Catalina Ortiz, Patricio Ross, Sigall Budnik, Sandra Solari, María de los Ángeles Vizcaya, Hanns Lembach, Roslye Berrios-Rojas, Felipe Melo-González, Mariana Ríos, Alexis M Kalergis, Susan M Bueno, Bruno Nervi
Publikováno v:
Clinical Infectious Diseases. 75:e594-e602
Background Inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been widely implemented in low- and middle-income countries. However, immunogenicity in immunocompromised patients has not been established. Herein, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb96c05f1b0f627acab52ee9ece9259
https://doi.org/10.1093/cid/ciac167
https://doi.org/10.1093/cid/ciac167